The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | R | Respiratory system | |
2 | R05 | Cough and cold preparations | |
3 | R05C | Expectorants, excl. combinations with cough suppressants | |
4 | R05CA | Expectorants |
Code | Title | |
---|---|---|
R05CA01 | Tyloxapol | |
R05CA02 | Potassium iodide | |
R05CA03 | Guaifenesin | |
R05CA04 | Ipecacuanha | |
R05CA05 | Altheae radix | |
R05CA06 | Senega | |
R05CA07 | Antimony pentasulfide | |
R05CA08 | Creosote | |
R05CA09 | Guaiacolsulfonate | |
R05CA10 | Combinations | |
R05CA11 | Levoverbenone | |
R05CA12 |
Active Ingredient | Description | |
---|---|---|
Guaiacolsulfonate |
|
|
Guaifenesin |
Guaifenesin is an expectorant the action of which promotes or facilitates the removal of secretions from the respiratory tract. The precise mechanism of action of guaifenesin is not known; however, it is thought to act as an expectorant by increasing the volume and reducing the viscosity of secretions in the trachea and bronchi. In turn, this may increase the efficiency of the cough reflex and facilitate removal of the secretions. Guaifenesin is over-the-counter drug for the treatment of cough and common cold. |
|
Hederae helicis folium |
|
|
Ipecacuanha |
Ipecacuanha root extract has been widely used in syrup form as a potent and effective emetic. Ipecacuanha powder had been used to induce sweating at the onset of influenza, and small amounts of the extract have been incorporated into cough syrups as expectorants. |
|
Potassium iodide |
Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities. |
|
Tyloxapol |
|
Title | Information Source | Document Type | |
---|---|---|---|
LEMSIP CHESTY COUGH Oral solution | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
ROBITUSSIN CHESTY COUGH MEDICINE Oral solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ROBITUSSIN COUGH AND CHEST CONGESTION Oral solution | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |